Sep 5 2006, 7:46 AM EST
MARKETWIRE
OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace, announced today that Broncus Technologies, Inc. of Mountain View, California has selected OmniComm's TrialMaster(R) Electronic Data Capture (EDC) and Trial Management Solution for conducting its IDE clinical trial of its Exhale(R) Drug Eluting Stent. The Exhale product is a novel bronchoscopic-based procedure and device being investigated to treat patients with emphysema. This global study will include sites located in North America, South America, Europe, and Australia.
TrialMaster is a flexible and easy to use web-based electronic data capture and trial management solution. TrialMaster optimizes the efficiency and accuracy of data collection while reducing the costs associated with paper-based clinical trials. With the TrialMaster solution, medical device companies such as Broncus can conduct clinical trials more effectively, using our software and services to provide end-to-end high quality data collection, data management and trial management solutions.
"Broncus requires complete and accurate collection of clinical research data and the ability to analyze the data in the shortest time possible after a database 'freeze' or lock. With TrialMaster we have the ability to practically eliminate the data visibility gap that occurs with paper-based trials. Utilizing the capabilities of OmniComm's EDC solution will enable Broncus to save time and money," said Dov Gal, VP, Clinical Affairs of Broncus. "We selected the TrialMaster solution because of its ease of use and flexible structure. Its integrated platform will enable Broncus to save valuable time and provide control over critical trial processes."
"It is a tribute to TrialMaster and our team that Broncus has chosen TrialMaster as its EDC solution," stated Cornelis Wit, President and CEO of OmniComm. "We are proud to be partnering with Broncus to support their data collection needs. Our TrialMaster solution provides companies such as Broncus with more efficient resource management and significant time and cost savings, allowing them to bring new treatment options to market more quickly and efficiently."
About Broncus Technologies, Inc.
Broncus Technologies is a privately held company headquartered in Mountain View, CA, developing interventional bronchoscopy devices for the treatment of emphysema. For more information, see www.broncus.com.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. (www.omnicomm.com) is one of the fastest growing companies in the EDC market place targeting its product TrialMaster(R) to the pharmaceutical, medical device and biotechnology companies as well as CROs. OmniComm's growing base of satisfied customers is a direct result of OmniComm's employee's commitment to on-time, quality and within budget performance.
The TrialMaster (www.trialmaster.com) system, the core product of OmniComm, provides trial sponsors with a 21 CRF Part 11 compliant Internet-based data and trial management solution that greatly increases the efficiency, security and integrity of clinical research data and thus significantly reduces the time and expense involved in conducting clinical studies.
Safe Harbor Disclaimer
Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All